Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Other Working Capital Changes (2020 - 2023)

Cullinan Therapeutics (CGEM) has 4 years of Other Working Capital Changes data on record, last reported at $3.3 million in Q4 2023.

  • For Q4 2023, Other Working Capital Changes rose 428.73% year-over-year to $3.3 million; the TTM value through Dec 2023 reached $5.9 million, up 426.02%, while the annual FY2025 figure was -$6.9 million, 379.0% down from the prior year.
  • Other Working Capital Changes reached $3.3 million in Q4 2023 per CGEM's latest filing, down from $3.8 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $4.4 million in Q1 2021 and bottomed at -$1.9 million in Q2 2023.
  • Average Other Working Capital Changes over 4 years is $647562.5, with a median of $598000.0 recorded in 2020.
  • The widest YoY moves for Other Working Capital Changes: up 801.84% in 2023, down 2028.89% in 2023.
  • A 4-year view of Other Working Capital Changes shows it stood at -$508000.0 in 2020, then crashed by 261.22% to -$1.8 million in 2021, then soared by 133.95% to $623000.0 in 2022, then skyrocketed by 428.73% to $3.3 million in 2023.
  • Per Business Quant database, its latest 3 readings for Other Working Capital Changes were $3.3 million in Q4 2023, $3.8 million in Q3 2023, and -$1.9 million in Q2 2023.